Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
United Therapeutics revenue
United Therapeutics's revenue is $2.9 billion.
What is United Therapeutics's revenue?
- United Therapeutics's revenue growth from 2000 to 2024 is 140,329.48%.
- United Therapeutics has 950 employees, and the revenue per employee ratio is $3,028,842.
- United Therapeutics's peak quarterly revenue was $748.9M in 2024(q3).
- United Therapeutics peak revenue was $2.9B in 2024.
- United Therapeutics annual revenue for 2023 was 2.3B, 20.2% growth from 2022.
- United Therapeutics annual revenue for 2024 was 2.9B, 23.63% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
United Therapeutics historical revenue
United Therapeutics's peak revenue was $2.9B in 2024. The peak quarterly revenue was $748.9M in 2024(q3).
United Therapeutics's revenue increased from $2.0m in 2000 to $2.9B currently. That's a 140,329.48% change in annual revenue.
United Therapeutics annual revenue
United Therapeutics annual revenue over time
| Fiscal year / year | United Therapeutics revenue |
|---|---|
| 2009 | $358.9M |
| 2010 | $592.9M |
| 2011 | $743.2M |
| 2012 | $916.1M |
| 2013 | $1.1B |
| 2014 | $1.3B |
| 2015 | $1.5B |
| 2016 | $1.6B |
| 2017 | $1.7B |
| 2018 | $1.6B |
| 2019 | $1.4B |
| 2020 | $1.5B |
| 2021 | $1.7B |
| 2022 | $1.9B |
| 2023 | $2.3B |
| 2024 | $2.9B |
Rate United Therapeutics' financial transparency
United Therapeutics annual growth
United Therapeutics saw the greatest revenue growth in 2002, when revenue increased by 425.56%.
United Therapeutics had the lowest revenue growth in 2019, when revenue changed by -11.0%.
United Therapeutics annual growth rate over time
| Year | United Therapeutics growth |
|---|---|
| 2009 | 27%↑ |
| 2010 | 65%↑ |
| 2011 | 25%↑ |
| 2012 | 23%↑ |
| 2013 | 22%↑ |
| 2014 | 15%↑ |
| 2015 | 14%↑ |
| 2016 | 9%↑ |
| 2017 | 8%↑ |
| 2018 | -6%↓ |
| 2019 | -11%↓ |
| 2020 | 2%↑ |
| 2021 | 14%↑ |
| 2022 | 15%↑ |
| 2023 | 20%↑ |
| 2024 | 24%↑ |
United Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
United Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $79.7M | $84.0M | $97.2M | $109.1M |
| 2010 | $128.9M | $134.7M | $168.6M | $163.7M |
| 2011 | $162.5M | $183.8M | $201.7M | $195.2M |
| 2012 | $204.2M | $225.6M | $242.5M | $243.8M |
| 2013 | $245.1M | $280.6M | $302.2M | $289.0M |
| 2014 | $289.4M | $322.8M | $330.0M | $346.3M |
| 2015 | $327.5M | $347.2M | $386.2M | $404.9M |
| 2016 | $369.0M | $412.6M | $408.2M | $409.0M |
| 2017 | $370.5M | $444.6M | $445.5M | $464.7M |
| 2018 | $389.2M | $444.5M | $412.7M | $381.4M |
| 2019 | $362.6M | $373.6M | $401.5M | $311.1M |
| 2020 | $356.3M | $362.0M | $380.1M | $384.9M |
| 2021 | $379.1M | $446.5M | $444.7M | $415.2M |
| 2022 | $461.9M | $466.9M | $516.0M | $491.5M |
| 2023 | $506.9M | $596.5M | $609.4M | $614.7M |
| 2024 | $677.7M | $714.9M | $748.9M | $735.9M |
United Therapeutics jobs nearby
Do you work at United Therapeutics?
Did United Therapeutics meet its revenue projections?
United Therapeutics financial information
| CEO | Martine A. Rothblatt Ph.D., Mba |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 950 |
| Date Founded | 1996 |
| Headquarters | Silver Spring, Maryland |
| Number of Locations | 7 |
| Revenue | $2.9B |
| Net Income | $727,300,000 |
| Gross Proft | $2.6B (2024) |
| PE Ratio | 4.22 |
| Tax Rate | 0.2% |
| Market Capitalization | $5.0B |
| Total Assets | $6,044,500,000 |
| Ticker | UTHR |
United Therapeutics jobs you might like
United Therapeutics competitors
United Therapeutics's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
United Therapeutics's smallest competitor is Novartis Consumer Health Inc with revenue of $6.4M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 853 |
| Regeneron | $85,589 | $14.2B | 9,123 | 390 |
| Vertex Pharmaceuticals | $95,952 | $11.0B | 3,400 | 294 |
| Moderna | $81,825 | $3.2B | 2,500 | 77 |
| Neurocrine Biosciences | $78,232 | $2.4B | 400 | 431 |
| Merck | $90,328 | $64.2B | 74,000 | 1,534 |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,742 |
| Medivation | $94,135 | $1.0B | 628 | - |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | 1 |
| Medicomp | $63,179 | $21.0M | 150 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
United Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of United Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about United Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at United Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by United Therapeutics. The data presented on this page does not represent the view of United Therapeutics and its employees or that of Zippia.
United Therapeutics may also be known as or be related to UNITED THERAPEUTICS CORP, United Therapeutics, United Therapeutics Corp. and United Therapeutics Corporation.